Gene One Life Science postpones extraordinary shareholders meeting to Nov. 30

Gene One Life Science revised its shareholder-meeting call, pushing the extraordinary meeting to Nov. 30, 2026 from Oct. 30. The voting record date shifted to Oct. 28, 2026 from Oct. 2. * Agenda scope expanded to include a proposed revision to executive retirement-benefit rules, alongside planned charter and board-related items. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gene One Life Science Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261014800361), on October 14, 2026, and is solely responsible for the information contained therein. (C)